Trial Profile
Efficacy of a fixed single-dose of plerixafor in poor mobilizers on hematopoietic stem cells mobilization
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2016 New trial record